Grace Therapeutics, Inc. (GRCE) vs Impact Biomedical Inc. (IBO)
Grace Therapeutics, Inc. and Impact Biomedical Inc. are both Biotechnology companies. Grace Therapeutics, Inc. and Impact Biomedical Inc. are of similar size ($48.3M and $45.4M). Grace Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 6.5×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the higher return on invested capital (−22.8% vs −43.4%). Across the 15 metrics below, Impact Biomedical Inc. leads on 8 and Grace Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | GRCE | IBO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (1,111.43%) | 65.16% |
| Operating margin | 0.00% | (14,600.00%) | 0.00% |
| Net margin | 0.00% | 2,254.29% | 0.00% |
| Free cash flow margin | 0.00% | (1,451.43%) | 0.00% |
| Return on equity | (36.19%) | 24.01% | (57.72%) |
| Return on assets | (33.74%) | 4.41% | (49.22%) |
| Return on invested capital | (43.36%) | (22.81%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack